Shadi Tabibian: Global Trends in Prenatal Diagnosis of Hemophilia A and B Over Two Decades
Shadi Tabibian, Director of the Iranian Comprehensive Hemophilia Care Center (ICHC) and Deputy of research at Blood Diseases Research Centers, Iran University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Proud to share our new publication:
‘Two decades of prenatal diagnosis in hemophilia A and B: a systematic review of global trends and current practices.’
In this PRISMA-guided systematic review, we mapped global trends in prenatal diagnosis (PND) for hemophilia A and B over the last 20 years (2005–September 2025). We included 24 studies covering 969 pregnancies.
Key highlights
- Predominant sampling approaches: amniocentesis (45.8%) and CVS (41.6%)
- A clear methodological shift from linkage analysis toward more definitive molecular strategies, including PCR and direct sequencing (each reported in 45.8% of studies)
- cfDNA/NIPT is emerging (reported in 20.8% of studies), but broader validation and implementation pathways remain needed
- Persistent gaps: substantial heterogeneity in access/reporting and limited pregnancy outcome data in many reports
Overall, the field has advanced substantially – yet there remains a critical need for standardized reporting, equitable access to genetic services, and stronger evidence to support non-invasive pathways.”
Title: Two decades of prenatal diagnosis in hemophilia A and B: a systematic review of global trends and current practices
Authors: Seyed Mehrab Safdari, Mehdi Bakhtiyaridovvombaigi, Fatemeh Damerchiloo, Akram Sadat Jaafarian, Fateme Amiri Samani, Majid Safa, Shadi Tabibian
Read the Full Article on Thrombosis Journal

Stay updated with Hemostasis Today.
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk
-
May 29, 2026, 09:50Maria Symiakaki: Advancing Cardiovascular Prevention at the 2026 Congress of the European Atherosclerosis Society